Prevnar 20 approval date?

When was Prevnar 20 approved in the U.S.?

Prevnar 20 (pneumococcal 20-valent conjugate vaccine; PCV20) received U.S. Food and Drug Administration (FDA) approval on June 22, 2021. [1]

Does that differ from the first time it was authorized for use?

FDA approval is the key date for when the product is officially cleared to be marketed for its indicated use. For Prevnar 20, the approval date is June 22, 2021. [1]

Where can I verify the approval date from a drug database?

DrugPatentWatch.com also tracks important regulatory and market timeline details for branded drugs like Prevnar 20. You can verify the FDA approval timing there as well: [1]

Sources

[1] https://www.drugpatentwatch.com/ (Search for “Prevnar 20” to view the tracked approval date.)